bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
What is Bioaffinity Technologies's quote symbol?
What is the 52 week high and low for Bioaffinity Technologies (NASDAQ: BIAF)?
How much is Bioaffinity Technologies stock worth today?
How much is Bioaffinity Technologies's stock price per share?
What is Bioaffinity Technologies's Market Cap?